/DISCLAIMER · RESEARCH_COMPOUND

This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.

/CAGRILINTIDE_10MG
Peptide

Cagrilintide

Amylin Analog for Appetite Regulation

/HALF_LIFE
6–8 days
/DELIVERY
Subcutaneous injection

/WHAT_IT_IS

Cagrilintide is a long-acting amylin analog that mimics the effects of the natural hormone amylin, helping regulate appetite and food intake.

/USAGE

Explored in weight loss studies due to its ability to enhance satiety and reduce caloric intake.

/MECHANISM_OF_ACTION

Binds to amylin and calcitonin receptors in the brain to regulate appetite and slow gastric emptying.

Reported Benefits

  • +Appetite suppression
  • +Weight loss support
  • +Improved satiety
  • +Potential synergy with GLP-1 agonists

Reported Side Effects

  • Nausea
  • Constipation
  • Injection site reactions

/STACKED_WITH

SemaglutideTirzepatideGLP-1 agonists

/RESEARCH_NOTES

Promising in co-therapy with GLP-1 receptor agonists for treating obesity.

/REFERENCE

https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00565
/TRACK_THIS

Browse all 89 in the app.

MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.

Last reviewed: 2026-06-04 · Reference only. Not medical advice. Consult a qualified physician.